Physician profile
Mark Gendi
NPI 1063075687
$12,153.19
in general payments reported to CMS, 2019-2025
19 companies · $4,964 in 2025
The $4,964 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.54 · 2020: $25.66 · 2021: $1,273 · 2022: $400 · 2023: $1,993 · 2024: $3,427 · 2025: $4,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,242 · Travel and Lodging: $3,932 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,242.04 |
| Travel and Lodging | $3,932.42 |
| Education | $209.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,752.21 | 2022-2025 | Mako, Insignia, Makoplasty |
| Zimmer Biomet Holdings, INC. | $2,026.73 | 2023-2025 | Avenir, Persona, Mymobility Platform |
| Titan Surgical Group, LLC | $1,371.33 | 2020-2024 | |
| Depuy Synthes Sales INC. | $263.99 | 2024-2025 | Attune, Tfn-Advance, Na |
| Innovation Technologies INC | $106.14 | 2023 | Irrisept |
| Medacta USA, INC. | $104.09 | 2024-2025 | Amistem |
| Pacira Pharmaceuticals Incorporated | $84.98 | 2024-2025 | Exparel, Zilretta, Iovera |
| Microport Orthopedics INC | $73.18 | 2021 | |
| Boston Scientific Corporation | $70.54 | 2019 | |
| Ferring Pharmaceuticals INC. | $55.22 | 2025 | Euflexxa |
| Skeletal Dynamics INC | $42.57 | 2024 | Geminus, Ijs, Align |
| Amgen INC. | $35.24 | 2024-2025 | Evenity, Prolia |
| Ucb, INC. | $34.21 | 2025 | Nayzilam |
| Vertex Pharmaceuticals Incorporated | $30.36 | 2025 | |
| Solventum Corporation | $25.05 | 2024 | Prevena |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $24.78 | 2025 | Vyepti |
| Avanos Medical | $23.21 | 2025 | On-Q Pump and Accessories |
| Checkpoint Surgical, INC | $15.45 | 2024 | Checkpoint Stimulators |
| Abbvie INC. | $13.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gendi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.